跳至主要内容
临床试验/ACTRN12617000793314
ACTRN12617000793314已完成2 期

A Pilot, Randomised, Double-Blind Study of Vitamin C in the treatment of Vasoplegic Shock after Cardiac Surgery

Austin Hospital0 个研究点目标入组 50 人开始时间: 2017年5月30日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged greater than or equal to 18 years
  • Admitted to the ICU for less than 6 hours following cardiac surgery
  • Vasoplegic syndrome in the postoperative period defined as:
  • a) need for continuous vasopressor infusion to maintain a mean arterial pressure greater than 65 mmHg AND
  • b) cardiac index equal to or greater than 2.2 L/min/m2 OR central venous O2 saturation less than 60%

排除标准

  • Use of vasopressors or inotropes in the preoperative period
  • Off-pump cardiac surgery
  • Chronic use of corticosteroid therapy
  • History of oxalate nephrolithiasis
  • Haemochromatosis
  • Glucose 6 phosphate dehydrogenase deficiency
  • Treating physician believes there is a cause for shock other than vasoplegic syndrome (eg: bleeding, fluid requirement, pneumothorax, pacemaker issues, or heart failure)
  • Treating clinician believes the study is not in the patient’s best interests

研究者

发起方
Austin Hospital

相似试验